Top Story

Sanofi and Verily launch diabetes management platform

October 23, 2016

In a joint venture, Sanofi and Verily are launching a diabetes management platform that will provide tools and technology to aid in improving daily life for patients, according to a press release from the companies.

The platform, called Onduo, will incorporate the expertise of Verily — a unit of Google parent, Alphabet — in miniaturized electronics, analytics and software with Sanofi’s focus on medicine and new therapies in order to help diabetes patients make better decisions and improve habits and outcomes. It is being developed with input from diabetes patients, clinicians, payers and health care professionals.

Antibody vaccine for treatment of type 1 diabetes enters preclinical trial

October 22, 2016
Neovac, a French company specializing in immunotherapies, will begin studying its interferon-alpha kinoid vaccine for the treatment of type 1 diabetes in collaboration…

Top 5 online thyroid stories posted in the last month

October 21, 2016
Endocrine Today has compiled a list of the top five news reports on the thyroid posted from Sept. 20 to Oct. 20. Healio.com/Endocrinology readers were interested in…
In the Journals Plus

Timing of daily walks improves glycemic profile in type 2 diabetes

October 21, 2016
Adults with type 2 diabetes saw lower postprandial blood glucose when they took three daily 10-minute walks after meals vs. when they took daily 30-minute walks at…
In the Journals Plus

With physical activity, ‘some is good but more is better’ for preventing type 2 diabetes

October 21, 2016
When it comes to physical activity, there is no clear cutoff point at which benefits are not achieved, but the risk for developing type 2 diabetes continues to decrease…
More News Headlines »

New Treatment Paradigms for Diabetic Retinopathy: Current Status and Applications for Practice

This activity is supported by an educational grant from Genentech, Inc.

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United…
More »
Meeting News Coverage

VIDEO: Researchers encouraged by number needed to treat with abaloparatide

September 22, 2016
More »
Cardiometabolic Health Congress

Cardiometabolic Health Congress


The Emerging Biosimilar Therapeutic Landscape: Scientific Foundations and Clinical Implications

This activity is supported by an educational grant from Boehringer-Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

Recent processes have been established to facilitate the production, validation, and utilization of biosimilars…
More »
Current Issues
View the Current Issues